BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 26163978)

  • 1. Breast Density Legislation: Discussion of Patient Utilization and Subsequent Direct Financial Ramifications for Insurance Providers.
    Sobotka J; Hinrichs C
    J Am Coll Radiol; 2015 Oct; 12(10):1011-5. PubMed ID: 26163978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The patient burden of screening mammography recall.
    Alcusky M; Philpotts L; Bonafede M; Clarke J; Skoufalos A
    J Womens Health (Larchmt); 2014 Sep; 23 Suppl 1():S11-9. PubMed ID: 25247382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial barriers to utilization of screening and treatment services for breast cancer: an equity analysis in Nigeria.
    Okoronkwo IL; Ejike-Okoye P; Chinweuba AU; Nwaneri AC
    Niger J Clin Pract; 2015; 18(2):287-91. PubMed ID: 25666009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the New Jersey Breast Density Law on Imaging and Intervention Volumes and Breast Cancer Diagnosis.
    Sanders LM; King AB; Goodman KS
    J Am Coll Radiol; 2016 Oct; 13(10):1189-1194. PubMed ID: 27318582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in mammography screening legislation across the states.
    Fowler BA
    J Womens Health Gend Based Med; 2000 Mar; 9(2):175-84. PubMed ID: 10746521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding patient options, utilization patterns, and burdens associated with breast cancer screening.
    Harvey SC; Vegesna A; Mass S; Clarke J; Skoufalos A
    J Womens Health (Larchmt); 2014 Sep; 23 Suppl 1():S3-9. PubMed ID: 25247383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient awareness of breast density and interest in supplemental screening tests: comparison of an academic facility and a county hospital.
    Trinh L; Ikeda DM; Miyake KK; Trinh J; Lee KK; Dave H; Hanafusa K; Lipson J
    J Am Coll Radiol; 2015 Mar; 12(3):249-55. PubMed ID: 25743922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dense breast legislation in the United States: state of the states.
    Dehkordy SF; Carlos RC
    J Am Coll Radiol; 2013 Dec; 10(12):899-902. PubMed ID: 24295937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Breast Density Notification Legislation on Radiologists' Practices of Reporting Breast Density: A Multi-State Study.
    Bahl M; Baker JA; Bhargavan-Chatfield M; Brandt EK; Ghate SV
    Radiology; 2016 Sep; 280(3):701-6. PubMed ID: 27018643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance goals for an adjunct diagnostic test to reduce unnecessary biopsies after screening mammography: analysis of costs, benefits, and consequences.
    Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
    J Am Coll Radiol; 2013 Dec; 10(12):924-30. PubMed ID: 24295942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Call for Fertility Preservation Coverage for Breast Cancer Patients: The Cost of Consistency.
    Walter JR; Xu S; Woodruff TK
    J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28376233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast density legislation: mandatory disclosure to patients, alternative screening, billing, reimbursement.
    Ray KM; Price ER; Joe BN
    AJR Am J Roentgenol; 2015 Feb; 204(2):257-60. PubMed ID: 25615746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of mammography screening for breast cancer in a low socioeconomic group of Iranian women.
    Barfar E; Rashidian A; Hosseini H; Nosratnejad S; Barooti E; Zendehdel K
    Arch Iran Med; 2014 Apr; 17(4):241-5. PubMed ID: 24724599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dense breasts: a review of reporting legislation and available supplemental screening options.
    Ho JM; Jafferjee N; Covarrubias GM; Ghesani M; Handler B
    AJR Am J Roentgenol; 2014 Aug; 203(2):449-56. PubMed ID: 25055284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of screening mammography participation and utilization in Canada.
    Doyle GP; Major D; Chu C; Stankiewicz A; Harrison ML; Pogany L; Mai VM; Onysko J
    Chronic Dis Inj Can; 2011 Sep; 31(4):152-6. PubMed ID: 21978638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dense Breast Legislation in the United States: State of the States.
    Dehkordy SF; Carlos RC
    J Am Coll Radiol; 2016 Nov; 13(11S):R53-R57. PubMed ID: 27814815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic aspects of MR-mammography in dense breasts.
    Kaiser CG; Reich C; Wasser K; Schönberg SO; Kaiser WA
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S69-71. PubMed ID: 23083609
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening Mammography Program of British Columbia: pattern of use and health care system costs.
    Olivotto IA; Kan L; Mates D; King S
    CMAJ; 1999 Feb; 160(3):337-41. PubMed ID: 10065075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in immediate breast reconstruction across insurance groups after enactment of breast cancer legislation.
    Yang RL; Newman AS; Lin IC; Reinke CE; Karakousis GC; Czerniecki BJ; Wu LC; Kelz RR
    Cancer; 2013 Jul; 119(13):2462-8. PubMed ID: 23585144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening.
    Feig S
    Radiol Clin North Am; 2010 Sep; 48(5):879-91. PubMed ID: 20868891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.